Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating different doses of LEO 138559 in adults with moderate-to-severe atopic dermatitis has completed enrollment and results have been post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• LEO 138559

Snippet

Sponsor: LEO Pharma | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2026-02-12